| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
99,662 |
90,054 |
$19.76M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
83,851 |
76,828 |
$15.96M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
74,895 |
68,592 |
$13.73M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
58,533 |
55,842 |
$10.40M |
| J9271 |
Injection, pembrolizumab, 1 mg |
942 |
743 |
$8.19M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
39,328 |
32,407 |
$7.27M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
42,177 |
40,277 |
$6.91M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
21,289 |
19,850 |
$6.17M |
| 99215 |
Prolong outpt/office vis |
22,551 |
19,867 |
$4.43M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
1,175 |
1,075 |
$4.14M |
| 70450 |
Computed tomography, head or brain; without contrast material |
12,514 |
12,005 |
$3.66M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
5,672 |
5,636 |
$3.38M |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
819 |
771 |
$3.28M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
17,719 |
16,380 |
$3.22M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
3,827 |
3,813 |
$3.20M |
| J7170 |
Injection, emicizumab-kxwh, 0.5 mg |
104 |
74 |
$3.13M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
25,971 |
9,923 |
$2.75M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
13,978 |
8,789 |
$2.63M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,846 |
8,643 |
$2.46M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
11,250 |
10,753 |
$2.29M |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
3,193 |
3,046 |
$2.23M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
13,003 |
10,535 |
$2.11M |
| G2067 |
Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) |
9,504 |
3,316 |
$2.06M |
| 36430 |
|
4,607 |
2,683 |
$1.81M |
| 96415 |
|
2,997 |
2,303 |
$1.76M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
8,660 |
8,628 |
$1.75M |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
1,841 |
1,833 |
$1.63M |
| J1950 |
Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
1,110 |
1,013 |
$1.59M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
2,404 |
2,392 |
$1.57M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
23,542 |
22,892 |
$1.53M |
| 80053 |
Comprehensive metabolic panel |
80,582 |
68,480 |
$1.53M |
| 90791 |
Psychiatric diagnostic evaluation |
1,590 |
1,488 |
$1.45M |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
2,806 |
2,014 |
$1.33M |
| H0020 |
Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) |
34,290 |
5,149 |
$1.25M |
| 86850 |
|
27,474 |
23,407 |
$1.23M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
80,836 |
71,540 |
$1.22M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,743 |
5,734 |
$1.17M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
4,510 |
3,659 |
$1.16M |
| 80076 |
|
52,006 |
47,958 |
$1.15M |
| H2012 |
Behavioral health day treatment, per hour |
10,897 |
868 |
$1.14M |
| 77336 |
|
2,423 |
1,289 |
$1.13M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
7,773 |
7,480 |
$1.09M |
| 99205 |
Prolong outpt/office vis |
5,373 |
5,322 |
$1.07M |
| 93458 |
|
604 |
600 |
$1.03M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
32,072 |
29,091 |
$1.01M |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
8,305 |
3,576 |
$970K |
| 87486 |
|
24,202 |
23,517 |
$858K |
| 59025 |
Fetal non-stress test |
2,994 |
2,575 |
$843K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
8,012 |
7,871 |
$832K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
594 |
473 |
$824K |
| 86901 |
|
28,978 |
22,561 |
$788K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,045 |
2,986 |
$770K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,798 |
3,794 |
$761K |
| 93970 |
|
1,403 |
1,351 |
$757K |
| 86900 |
|
31,284 |
23,491 |
$734K |
| 80061 |
Lipid panel |
32,445 |
32,121 |
$734K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
413 |
413 |
$723K |
| 97161 |
|
4,162 |
4,141 |
$663K |
| 36415 |
Collection of venous blood by venipuncture |
122,466 |
80,027 |
$648K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
32,081 |
29,116 |
$640K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
3,826 |
3,816 |
$596K |
| J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
434 |
176 |
$588K |
| 90834 |
Psychotherapy, 45 minutes with patient |
3,234 |
1,250 |
$587K |
| 77386 |
|
2,909 |
289 |
$580K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,974 |
1,928 |
$567K |
| 87536 |
|
10,010 |
9,515 |
$567K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
8,175 |
7,906 |
$545K |
| 93975 |
|
803 |
784 |
$517K |
| J0897 |
Injection, denosumab, 1 mg |
362 |
349 |
$510K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,839 |
2,832 |
$506K |
| 77412 |
|
1,462 |
193 |
$488K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
5,311 |
2,570 |
$484K |
| 87581 |
|
24,171 |
23,507 |
$474K |
| 12001 |
|
929 |
923 |
$470K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
24,565 |
23,808 |
$463K |
| 12011 |
|
831 |
828 |
$444K |
| Q5117 |
Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg |
445 |
308 |
$437K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
14,778 |
14,190 |
$430K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
15,951 |
15,811 |
$427K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
11,381 |
4,731 |
$427K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,257 |
2,182 |
$425K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
237 |
221 |
$418K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,232 |
1,209 |
$412K |
| 77334 |
|
1,123 |
881 |
$406K |
| 19301 |
|
156 |
154 |
$379K |
| 58558 |
|
273 |
271 |
$378K |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
493 |
430 |
$375K |
| 82803 |
|
17,114 |
15,370 |
$360K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
775 |
764 |
$355K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
670 |
469 |
$344K |
| 76770 |
|
652 |
642 |
$341K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
234 |
234 |
$336K |
| J2323 |
Injection, natalizumab, 1 mg |
49 |
49 |
$329K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
9,175 |
8,940 |
$328K |
| 16020 |
|
651 |
632 |
$328K |
| 97803 |
|
7,756 |
7,148 |
$313K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
695 |
690 |
$310K |
| 10060 |
|
798 |
778 |
$295K |
| 99385 |
|
1,584 |
1,578 |
$294K |
| 96367 |
|
2,897 |
2,313 |
$288K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
349 |
143 |
$288K |
| 86480 |
|
4,738 |
4,725 |
$282K |
| 83880 |
|
10,149 |
9,633 |
$268K |
| 99386 |
|
1,534 |
1,531 |
$268K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
15,408 |
11,966 |
$262K |
| 90686 |
|
14,389 |
14,362 |
$254K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
18,377 |
15,818 |
$226K |
| 97802 |
|
4,352 |
4,300 |
$218K |
| 76830 |
Ultrasound, transvaginal |
5,112 |
4,828 |
$217K |
| 90715 |
|
8,729 |
8,676 |
$212K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,378 |
5,168 |
$209K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
8,130 |
8,109 |
$199K |
| 47562 |
|
67 |
67 |
$192K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
4,009 |
3,805 |
$192K |
| 88342 |
|
2,668 |
2,059 |
$191K |
| J3490 |
Unclassified drugs |
1,545 |
1,231 |
$185K |
| 90651 |
|
2,970 |
2,968 |
$176K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,047 |
1,026 |
$175K |
| 96416 |
|
220 |
119 |
$169K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
26,025 |
23,730 |
$167K |
| 77300 |
|
735 |
687 |
$167K |
| 90677 |
|
3,032 |
3,028 |
$165K |
| 36416 |
|
6,372 |
6,127 |
$163K |
| J0185 |
Injection, aprepitant, 1 mg |
1,949 |
1,345 |
$159K |
| 93351 |
|
361 |
359 |
$146K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
827 |
769 |
$140K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
864 |
335 |
$135K |
| 96402 |
|
1,569 |
1,388 |
$124K |
| J1756 |
Injection, iron sucrose, 1 mg |
2,500 |
1,328 |
$123K |
| 20610 |
|
414 |
389 |
$122K |
| J0741 |
Injection, cabotegravir and rilpivirine, 2mg/3mg |
98 |
96 |
$122K |
| 90750 |
|
935 |
934 |
$119K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
346 |
342 |
$117K |
| 87799 |
|
5,000 |
2,025 |
$117K |
| 43235 |
|
166 |
165 |
$115K |
| 77290 |
|
274 |
231 |
$115K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
120,014 |
100,767 |
$115K |
| 93971 |
|
1,733 |
1,691 |
$112K |
| 77338 |
|
298 |
284 |
$111K |
| 97165 |
|
815 |
814 |
$110K |
| 70486 |
|
1,819 |
1,782 |
$109K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
182 |
180 |
$109K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
3,876 |
3,872 |
$106K |
| 90832 |
Psychotherapy, 30 minutes with patient |
807 |
453 |
$104K |
| 96417 |
|
2,927 |
1,953 |
$104K |
| 42830 |
|
61 |
61 |
$102K |
| 70496 |
|
334 |
330 |
$99K |
| Q5115 |
Injection, rituximab-abbs, biosimilar, (truxima), 10 mg |
43 |
24 |
$98K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
53,575 |
45,630 |
$97K |
| 29125 |
|
356 |
348 |
$96K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
40 |
30 |
$95K |
| 91322 |
|
1,270 |
1,268 |
$94K |
| 96409 |
|
1,296 |
871 |
$94K |
| 71250 |
|
560 |
557 |
$94K |
| 86902 |
|
2,728 |
1,241 |
$92K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,353 |
2,311 |
$90K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,054 |
730 |
$89K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
20,936 |
17,542 |
$89K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
761 |
327 |
$89K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
934 |
535 |
$88K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
731 |
698 |
$87K |
| 97116 |
|
1,456 |
930 |
$87K |
| 71046 |
Radiologic examination, chest; 2 views |
22,165 |
21,346 |
$83K |
| 85610 |
|
31,620 |
29,369 |
$83K |
| 70491 |
|
264 |
260 |
$82K |
| 99381 |
|
389 |
386 |
$81K |
| 90697 |
|
3,180 |
3,161 |
$80K |
| 58100 |
|
132 |
132 |
$80K |
| 87497 |
|
3,597 |
2,069 |
$80K |
| 12002 |
|
154 |
152 |
$78K |
| 83655 |
|
5,073 |
5,067 |
$76K |
| 86359 |
|
3,399 |
3,332 |
$76K |
| 54161 |
|
69 |
69 |
$75K |
| 86360 |
|
3,353 |
3,306 |
$74K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,236 |
3,162 |
$73K |
| 19083 |
|
44 |
42 |
$73K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
167 |
124 |
$72K |
| 87507 |
|
1,161 |
1,145 |
$72K |
| 83970 |
|
2,390 |
2,302 |
$67K |
| G0397 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes |
397 |
350 |
$66K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
492 |
418 |
$65K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
340 |
315 |
$64K |
| 92551 |
|
710 |
710 |
$63K |
| 90670 |
|
5,247 |
5,224 |
$61K |
| 96411 |
|
1,870 |
1,242 |
$60K |
| 86923 |
|
2,933 |
1,670 |
$58K |
| 86356 |
|
1,808 |
1,783 |
$58K |
| 76000 |
|
1,325 |
1,292 |
$57K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17,347 |
17,040 |
$57K |
| 38222 |
|
111 |
109 |
$56K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
703 |
698 |
$53K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
1,105 |
1,102 |
$52K |
| 99401 |
|
632 |
630 |
$50K |
| 58662 |
|
37 |
36 |
$50K |
| 84443 |
Thyroid stimulating hormone (TSH) |
27,214 |
26,339 |
$49K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
28,310 |
27,858 |
$47K |
| 77332 |
|
114 |
86 |
$46K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
223 |
223 |
$46K |
| C1781 |
Mesh (implantable) |
301 |
296 |
$46K |
| 76098 |
|
209 |
201 |
$45K |
| 71045 |
Radiologic examination, chest; single view |
9,303 |
8,848 |
$45K |
| C1769 |
Guide wire |
3,299 |
3,168 |
$44K |
| Q0139 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis) |
182 |
134 |
$44K |
| 90681 |
|
3,641 |
3,632 |
$44K |
| 77001 |
|
113 |
113 |
$44K |
| 76942 |
|
229 |
222 |
$44K |
| 99383 |
|
210 |
210 |
$43K |
| 88307 |
|
657 |
526 |
$43K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
354 |
347 |
$43K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
609 |
339 |
$42K |
| 86355 |
|
2,257 |
2,220 |
$42K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
211 |
154 |
$41K |
| 92526 |
|
210 |
119 |
$41K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
201 |
201 |
$41K |
| 90656 |
|
3,248 |
3,245 |
$40K |
| 77301 |
|
246 |
238 |
$40K |
| 90619 |
|
1,162 |
1,161 |
$40K |
| 81025 |
|
11,864 |
11,413 |
$39K |
| 99384 |
|
197 |
197 |
$38K |
| 20611 |
|
65 |
60 |
$38K |
| 90698 |
|
4,236 |
4,221 |
$38K |
| 73700 |
|
171 |
166 |
$37K |
| 90836 |
|
353 |
172 |
$37K |
| D1110 |
Prophylaxis - adult |
364 |
262 |
$37K |
| 86357 |
|
2,244 |
2,207 |
$37K |
| 87653 |
|
1,630 |
1,624 |
$36K |
| 30140 |
|
12 |
12 |
$35K |
| J7050 |
Infusion, normal saline solution, 250 cc |
17,156 |
11,870 |
$35K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
275 |
250 |
$35K |
| 0001A |
|
1,148 |
1,143 |
$35K |
| 90633 |
|
3,474 |
3,472 |
$34K |
| J9070 |
Cyclophosphamide, 100 mg |
182 |
109 |
$33K |
| 96401 |
|
625 |
305 |
$33K |
| 0124A |
|
889 |
883 |
$33K |
| 49650 |
|
13 |
13 |
$33K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
14,697 |
14,548 |
$32K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
27,962 |
25,907 |
$32K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,542 |
3,051 |
$31K |
| 82728 |
|
12,377 |
11,847 |
$31K |
| 87522 |
Neg quan hep c or qual rna |
870 |
851 |
$30K |
| 77065 |
Tomosynthesis, mammo |
336 |
315 |
$30K |
| 85027 |
|
24,755 |
23,733 |
$28K |
| 90707 |
|
1,997 |
1,995 |
$28K |
| 86769 |
|
1,597 |
1,468 |
$28K |
| 52356 |
|
13 |
13 |
$27K |
| 93976 |
|
41 |
40 |
$27K |
| 77373 |
|
38 |
12 |
$27K |
| 0002A |
|
773 |
773 |
$26K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
31 |
31 |
$26K |
| 72197 |
|
49 |
49 |
$25K |
| 76937 |
|
122 |
120 |
$25K |
| 29130 |
|
93 |
93 |
$25K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,322 |
1,273 |
$24K |
| 87517 |
|
867 |
692 |
$23K |
| 90716 |
|
1,806 |
1,806 |
$23K |
| J9267 |
Injection, paclitaxel, 1 mg |
1,393 |
674 |
$23K |
| 86880 |
|
855 |
702 |
$23K |
| 81001 |
|
34,259 |
31,878 |
$23K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
633 |
571 |
$23K |
| 86803 |
|
11,303 |
11,200 |
$23K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
92 |
83 |
$22K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
3,115 |
1,928 |
$22K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
333 |
290 |
$22K |
| 85055 |
|
622 |
568 |
$22K |
| 84439 |
|
10,377 |
9,302 |
$22K |
| 90480 |
|
1,074 |
1,073 |
$21K |
| 86922 |
|
684 |
316 |
$21K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12,576 |
11,877 |
$21K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
24,609 |
22,693 |
$21K |
| 82962 |
|
24,577 |
19,381 |
$21K |
| T1023 |
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter |
364 |
294 |
$21K |
| C1874 |
Stent, coated/covered, with delivery system |
70 |
69 |
$21K |
| 84403 |
|
2,406 |
2,052 |
$21K |
| H0001 |
Alcohol and/or drug assessment |
112 |
103 |
$20K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
642 |
637 |
$20K |
| 82607 |
|
7,367 |
7,291 |
$20K |
| 82784 |
|
5,176 |
3,136 |
$20K |
| 80047 |
|
1,085 |
980 |
$19K |
| 96376 |
|
3,836 |
3,492 |
$19K |
| 99242 |
|
88 |
82 |
$19K |
| 84702 |
|
13,044 |
11,929 |
$19K |
| 72141 |
|
100 |
99 |
$18K |
| 83735 |
|
22,603 |
18,338 |
$18K |
| 83615 |
|
10,757 |
7,895 |
$18K |
| J9045 |
Injection, carboplatin, 50 mg |
1,014 |
664 |
$18K |
| 90674 |
|
609 |
609 |
$18K |
| 36561 |
|
14 |
14 |
$18K |
| Q3014 |
Telehealth originating site facility fee |
1,504 |
1,362 |
$18K |
| 90734 |
|
1,392 |
1,391 |
$18K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
1,821 |
1,762 |
$18K |
| 58300 |
|
93 |
93 |
$18K |
| 92610 |
|
95 |
95 |
$17K |
| J3489 |
Injection, zoledronic acid, 1 mg |
413 |
401 |
$17K |
| 84484 |
|
29,532 |
19,514 |
$17K |
| 96377 |
|
365 |
293 |
$17K |
| 76999 |
|
224 |
216 |
$16K |
| 77280 |
|
41 |
39 |
$16K |
| 88341 |
|
1,053 |
607 |
$16K |
| 86592 |
|
17,496 |
17,243 |
$16K |
| 87631 |
|
252 |
250 |
$16K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
196 |
52 |
$16K |
| 70487 |
|
50 |
50 |
$16K |
| 85730 |
|
23,390 |
22,172 |
$16K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
13,314 |
11,757 |
$16K |
| 90710 |
|
1,300 |
1,298 |
$16K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
48 |
48 |
$15K |
| 85014 |
|
16,656 |
15,609 |
$15K |
| 90732 |
|
428 |
427 |
$15K |
| 86870 |
|
355 |
285 |
$15K |
| 54150 |
|
14 |
14 |
$15K |
| 90744 |
|
1,788 |
1,782 |
$15K |
| 74178 |
|
69 |
68 |
$15K |
| 87481 |
|
596 |
317 |
$14K |
| 70547 |
|
28 |
27 |
$14K |
| 91321 |
|
291 |
291 |
$14K |
| 90696 |
|
1,244 |
1,242 |
$14K |
| 50200 |
|
12 |
12 |
$14K |
| 96161 |
|
255 |
241 |
$14K |
| 87340 |
|
9,631 |
9,512 |
$14K |
| 0003A |
|
361 |
361 |
$14K |
| 90620 |
|
616 |
615 |
$14K |
| 36591 |
|
186 |
164 |
$13K |
| 0054A |
|
369 |
369 |
$13K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
408 |
392 |
$13K |
| 72131 |
|
97 |
97 |
$13K |
| 94375 |
|
161 |
159 |
$13K |
| 76870 |
|
542 |
528 |
$13K |
| 96156 |
|
47 |
43 |
$12K |
| 88112 |
|
247 |
221 |
$12K |
| 70498 |
|
289 |
286 |
$12K |
| 90658 |
|
955 |
953 |
$12K |
| 96368 |
|
685 |
526 |
$11K |
| 94726 |
|
68 |
67 |
$11K |
| 81513 |
|
412 |
410 |
$11K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
5,799 |
3,398 |
$11K |
| 84153 |
|
2,944 |
2,867 |
$11K |
| 74183 |
|
51 |
51 |
$11K |
| 51798 |
|
29 |
28 |
$11K |
| 84100 |
|
11,283 |
8,823 |
$11K |
| 86334 |
|
2,272 |
2,084 |
$10K |
| 83540 |
|
10,692 |
10,441 |
$10K |
| 83550 |
|
10,243 |
10,014 |
$10K |
| 31575 |
|
543 |
450 |
$10K |
| 73562 |
|
4,140 |
3,842 |
$10K |
| 83605 |
|
19,161 |
16,345 |
$10K |
| 96450 |
|
13 |
12 |
$10K |
| 51741 |
|
29 |
28 |
$10K |
| 99243 |
|
46 |
45 |
$10K |
| 99173 |
|
367 |
366 |
$10K |
| 82670 |
|
908 |
832 |
$9K |
| 83883 |
|
3,302 |
1,776 |
$9K |
| 82043 |
|
7,506 |
6,850 |
$9K |
| 99051 |
|
603 |
588 |
$9K |
| 84703 |
|
6,484 |
6,269 |
$9K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
700 |
655 |
$9K |
| 76857 |
|
574 |
559 |
$9K |
| 97162 |
|
50 |
50 |
$9K |
| 82378 |
|
1,992 |
1,642 |
$8K |
| 82746 |
|
3,389 |
3,343 |
$8K |
| D0120 |
Periodic oral evaluation - established patient |
91 |
91 |
$8K |
| 80197 |
|
3,313 |
1,877 |
$8K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
13 |
13 |
$8K |
| 86706 |
|
4,698 |
4,658 |
$8K |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
514 |
317 |
$8K |
| 83516 |
|
1,849 |
1,408 |
$8K |
| 85045 |
|
5,397 |
4,414 |
$8K |
| 94729 |
|
277 |
275 |
$8K |
| P9037 |
Platelets, pheresis, leukocytes reduced, irradiated, each unit |
21 |
13 |
$8K |
| J9370 |
Vincristine sulfate, 1 mg |
861 |
616 |
$7K |
| 0134A |
|
173 |
173 |
$7K |
| 81003 |
|
20,163 |
17,904 |
$7K |
| 86140 |
|
9,693 |
9,249 |
$7K |
| 83020 |
|
2,211 |
2,130 |
$7K |
| 64615 |
|
12 |
12 |
$7K |
| C1760 |
Closure device, vascular (implantable/insertable) |
293 |
285 |
$7K |
| 90381 |
|
158 |
158 |
$7K |
| 86704 |
|
4,515 |
4,477 |
$7K |
| 97760 |
|
71 |
69 |
$7K |
| 86765 |
|
3,489 |
3,432 |
$7K |
| 88360 |
|
88 |
54 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,451 |
3,237 |
$7K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
7,627 |
7,023 |
$7K |
| 0072A |
|
162 |
162 |
$6K |
| 92523 |
|
26 |
26 |
$6K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,685 |
1,673 |
$6K |
| 90694 |
|
494 |
493 |
$6K |
| 76818 |
|
64 |
43 |
$6K |
| 99406 |
|
97 |
94 |
$6K |
| 86762 |
|
3,209 |
3,158 |
$6K |
| 80329 |
|
2,396 |
1,972 |
$6K |
| 83690 |
|
21,413 |
20,151 |
$6K |
| 87529 |
|
227 |
121 |
$6K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15,696 |
14,550 |
$6K |
| 99429 |
|
491 |
439 |
$6K |
| 83001 |
|
1,406 |
1,386 |
$6K |
| J1453 |
Injection, fosaprepitant, 1 mg |
39 |
26 |
$6K |
| 94010 |
|
44 |
44 |
$6K |
| 82330 |
|
11,494 |
10,484 |
$6K |
| J2704 |
Injection, propofol, 10 mg |
29,253 |
22,305 |
$6K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
41 |
41 |
$6K |
| 90691 |
|
82 |
82 |
$5K |
| 90680 |
|
579 |
578 |
$5K |
| 88304 |
|
994 |
933 |
$5K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
49 |
25 |
$5K |
| 93270 |
|
35 |
32 |
$5K |
| 86787 |
|
3,069 |
3,022 |
$5K |
| 29515 |
|
19 |
19 |
$5K |
| 73610 |
|
3,375 |
3,126 |
$5K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,240 |
1,209 |
$5K |
| 87040 |
|
6,401 |
4,125 |
$5K |
| 0071A |
|
130 |
130 |
$5K |
| 93017 |
|
27 |
27 |
$5K |
| 84550 |
|
4,473 |
3,378 |
$5K |
| 86708 |
|
3,126 |
3,099 |
$5K |
| 0064A |
|
152 |
152 |
$5K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
29 |
29 |
$5K |
| 90648 |
|
326 |
324 |
$5K |
| 86780 |
|
1,640 |
1,616 |
$5K |
| 99245 |
|
25 |
25 |
$5K |
| 73630 |
|
3,280 |
3,114 |
$5K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
314 |
307 |
$4K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
18 |
18 |
$4K |
| 96127 |
|
1,251 |
1,231 |
$4K |
| 86703 |
|
278 |
278 |
$4K |
| 90700 |
|
245 |
245 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
6,602 |
5,933 |
$4K |
| 83002 |
|
971 |
917 |
$4K |
| 84146 |
|
1,102 |
1,072 |
$4K |
| 93226 |
|
18 |
17 |
$4K |
| 84165 |
|
2,313 |
2,093 |
$4K |
| 80320 |
|
5,416 |
5,167 |
$4K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
5,454 |
4,288 |
$4K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
4,812 |
3,176 |
$4K |
| 87070 |
|
6,040 |
5,741 |
$4K |
| C1729 |
Catheter, drainage |
259 |
204 |
$4K |
| 96160 |
|
122 |
120 |
$4K |
| 85652 |
|
7,769 |
7,433 |
$4K |
| 73030 |
|
2,429 |
2,288 |
$4K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
944 |
923 |
$3K |
| 90380 |
|
71 |
71 |
$3K |
| J8501 |
Aprepitant, oral, 5 mg |
541 |
516 |
$3K |
| 83021 |
|
998 |
979 |
$3K |
| 71270 |
|
27 |
26 |
$3K |
| 99382 |
|
17 |
17 |
$3K |
| 82105 |
|
1,886 |
1,829 |
$3K |
| 73110 |
|
2,374 |
2,111 |
$3K |
| C1819 |
Surgical tissue localization and excision device (implantable) |
72 |
68 |
$3K |
| 73130 |
|
2,733 |
2,501 |
$3K |
| 90746 |
|
103 |
103 |
$3K |
| 87077 |
|
3,659 |
3,202 |
$3K |
| 90649 |
|
104 |
104 |
$3K |
| D6999 |
|
15 |
12 |
$3K |
| 85379 |
|
4,509 |
4,387 |
$3K |
| 86709 |
|
2,071 |
2,053 |
$3K |
| 73502 |
|
1,489 |
1,400 |
$3K |
| C1726 |
Catheter, balloon dilatation, non-vascular |
12 |
12 |
$3K |
| 87625 |
|
496 |
487 |
$3K |
| 77012 |
|
15 |
15 |
$3K |
| 89051 |
|
785 |
659 |
$3K |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
3,523 |
3,470 |
$3K |
| 90672 |
|
179 |
179 |
$3K |
| 86300 |
|
678 |
486 |
$3K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
46 |
24 |
$3K |
| 84436 |
|
1,839 |
1,734 |
$3K |
| 93304 |
|
15 |
14 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
91 |
89 |
$3K |
| D9999 |
Unspecified adjunctive procedure, by report |
16 |
14 |
$3K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
18 |
12 |
$3K |
| 85018 |
|
4,544 |
4,525 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
20,065 |
17,923 |
$2K |
| 82977 |
|
1,755 |
1,567 |
$2K |
| 82570 |
|
4,261 |
3,705 |
$2K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
1,019 |
916 |
$2K |
| 88142 |
|
92 |
92 |
$2K |
| 87186 |
|
4,086 |
3,714 |
$2K |
| 86735 |
|
711 |
706 |
$2K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
465 |
458 |
$2K |
| 73590 |
|
1,783 |
1,677 |
$2K |
| 86039 |
|
1,154 |
1,146 |
$2K |
| 84445 |
|
65 |
63 |
$2K |
| 82550 |
|
2,939 |
2,711 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
3,518 |
2,007 |
$2K |
| OP250 |
|
1,509 |
987 |
$2K |
| 82950 |
|
2,244 |
2,233 |
$2K |
| 93325 |
|
32 |
29 |
$2K |
| J9190 |
Injection, fluorouracil, 500 mg |
113 |
52 |
$2K |
| 86593 |
|
1,612 |
1,589 |
$2K |
| 90739 |
|
25 |
25 |
$2K |
| 84479 |
|
1,312 |
1,232 |
$2K |
| 99241 |
|
12 |
12 |
$2K |
| 87533 |
|
92 |
51 |
$2K |
| 84270 |
|
895 |
886 |
$2K |
| 86376 |
|
581 |
568 |
$2K |
| 84156 |
|
2,998 |
2,716 |
$2K |
| 82248 |
|
1,866 |
1,570 |
$2K |
| 86800 |
|
491 |
456 |
$2K |
| C1758 |
Catheter, ureteral |
518 |
510 |
$2K |
| 76641 |
|
62 |
55 |
$2K |
| 80050 |
General health panel |
113 |
110 |
$2K |
| 85384 |
|
893 |
773 |
$2K |
| 87081 |
|
3,841 |
3,710 |
$2K |
| 76801 |
|
12 |
12 |
$2K |
| 72170 |
|
1,636 |
1,611 |
$2K |
| 90675 |
|
26 |
13 |
$2K |
| 87900 |
|
25 |
24 |
$2K |
| 93225 |
|
30 |
29 |
$2K |
| 86317 |
|
792 |
665 |
$2K |
| 90653 |
|
169 |
169 |
$2K |
| 85245 |
|
54 |
54 |
$1K |
| 73140 |
|
939 |
898 |
$1K |
| 83010 |
|
782 |
656 |
$1K |
| 90657 |
|
99 |
99 |
$1K |
| 80164 |
|
454 |
440 |
$1K |
| 87205 |
|
4,412 |
4,099 |
$1K |
| 84154 |
|
423 |
419 |
$1K |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
153 |
150 |
$1K |
| 82150 |
|
1,074 |
956 |
$1K |
| 83520 |
|
575 |
513 |
$1K |
| 82565 |
|
5,257 |
4,928 |
$1K |
| 93320 |
|
15 |
12 |
$1K |
| 0111A |
|
32 |
32 |
$1K |
| J9394 |
Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg |
16 |
14 |
$1K |
| 99177 |
|
54 |
54 |
$1K |
| 72100 |
|
1,059 |
1,054 |
$1K |
| 86665 |
|
829 |
452 |
$1K |
| 86301 |
|
565 |
504 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,029 |
4,386 |
$1K |
| J1610 |
Injection, glucagon hydrochloride, per 1 mg |
14 |
13 |
$1K |
| 82947 |
|
5,158 |
4,828 |
$1K |
| 86304 |
|
930 |
818 |
$1K |
| 76536 |
|
115 |
114 |
$1K |
| 90611 |
|
83 |
82 |
$1K |
| 86038 |
|
718 |
713 |
$1K |
| 85240 |
|
122 |
113 |
$1K |
| 73560 |
|
561 |
539 |
$1K |
| 84480 |
|
681 |
660 |
$1K |
| 82232 |
|
241 |
230 |
$1K |
| 84145 |
|
1,302 |
1,256 |
$989.22 |
| 86160 |
|
681 |
366 |
$988.79 |
| 85246 |
|
55 |
54 |
$984.46 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
592 |
531 |
$977.96 |
| 73080 |
|
1,350 |
1,292 |
$976.48 |
| 86335 |
|
30 |
29 |
$947.09 |
| 86696 |
|
345 |
341 |
$943.38 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
17,581 |
16,301 |
$932.38 |
| 95886 |
|
13 |
13 |
$929.75 |
| 83993 |
|
288 |
285 |
$904.83 |
| 90662 |
|
69 |
68 |
$902.14 |
| 73090 |
|
1,307 |
1,200 |
$900.52 |
| 87493 |
|
107 |
107 |
$898.95 |
| C9145 |
Injection, aprepitant, (aponvie), 1 mg |
14 |
14 |
$897.84 |
| 91200 |
|
139 |
139 |
$874.86 |
| 73552 |
|
611 |
577 |
$873.08 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
14 |
13 |
$857.28 |
| 80179 |
|
1,491 |
1,443 |
$848.72 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
18,216 |
17,187 |
$776.43 |
| 93923 |
|
15 |
12 |
$754.65 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
85 |
62 |
$732.77 |
| 74019 |
|
1,077 |
1,055 |
$718.96 |
| 84425 |
|
222 |
218 |
$718.45 |
| 84460 |
|
1,514 |
1,508 |
$716.33 |
| 84450 |
|
1,438 |
1,432 |
$713.67 |
| 87147 |
|
2,892 |
2,335 |
$705.46 |
| 87181 |
|
1,148 |
1,069 |
$704.40 |
| 84132 |
|
5,216 |
4,546 |
$688.22 |
| J9201 |
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
31 |
13 |
$686.31 |
| G0008 |
Administration of influenza virus vaccine |
694 |
694 |
$682.47 |
| J9073 |
Injection, cyclophosphamide (dr. reddy's), 5 mg |
17 |
14 |
$661.36 |
| 82533 |
|
213 |
205 |
$657.37 |
| 90713 |
|
52 |
52 |
$651.00 |
| 0112A |
|
19 |
19 |
$638.00 |
| 87102 |
|
982 |
854 |
$619.57 |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,198 |
2,068 |
$611.48 |
| 84481 |
|
217 |
212 |
$598.98 |
| 80178 |
|
260 |
251 |
$587.92 |
| 83521 |
|
252 |
122 |
$584.65 |
| 84295 |
|
5,759 |
5,418 |
$580.62 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
4,440 |
3,592 |
$568.38 |
| 83525 |
|
183 |
179 |
$568.18 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,348 |
1,672 |
$550.44 |
| 72128 |
|
13 |
13 |
$538.47 |
| 82435 |
|
4,770 |
4,458 |
$533.11 |
| 95940 |
|
12 |
12 |
$522.32 |
| 82652 |
|
25 |
25 |
$518.43 |
| 0074A |
|
14 |
14 |
$480.00 |
| 88300 |
|
308 |
267 |
$478.70 |
| 80177 |
|
127 |
120 |
$466.05 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,122 |
831 |
$449.36 |
| 86147 |
|
142 |
82 |
$442.91 |
| 90723 |
|
38 |
38 |
$420.33 |
| 90621 |
|
24 |
24 |
$417.64 |
| 85660 |
|
557 |
446 |
$400.72 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,655 |
3,197 |
$398.87 |
| 86695 |
|
168 |
165 |
$396.02 |
| 90678 |
|
19 |
19 |
$388.50 |
| 73521 |
|
202 |
199 |
$387.09 |
| 91312 |
|
46 |
46 |
$380.66 |
| 86003 |
|
25 |
24 |
$358.50 |
| 15853 |
|
29 |
29 |
$353.97 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,388 |
1,239 |
$349.96 |
| 87206 |
|
943 |
588 |
$343.84 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
10,653 |
9,662 |
$340.85 |
| 74018 |
|
229 |
218 |
$339.41 |
| D0999 |
Unspecified diagnostic procedure, by report |
184 |
163 |
$335.23 |
| 87593 |
|
24 |
13 |
$331.86 |
| 86431 |
|
405 |
402 |
$327.99 |
| 73060 |
|
537 |
506 |
$320.65 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
371 |
366 |
$312.32 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
572 |
561 |
$303.04 |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
27 |
13 |
$300.89 |
| 86235 |
|
164 |
92 |
$297.70 |
| 90660 |
|
25 |
25 |
$290.90 |
| 86705 |
|
222 |
214 |
$284.79 |
| 84590 |
|
158 |
158 |
$272.84 |
| 91320 |
|
18 |
18 |
$262.20 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
833 |
660 |
$259.12 |
| 0011A |
|
21 |
21 |
$258.02 |
| J0184 |
Injection, amisulpride, 1 mg |
148 |
145 |
$257.83 |
| 86644 |
|
182 |
181 |
$256.36 |
| 86777 |
|
151 |
150 |
$247.77 |
| 84630 |
|
223 |
220 |
$246.12 |
| 84207 |
|
12 |
12 |
$235.36 |
| 87116 |
|
340 |
275 |
$226.18 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
1,036 |
1,020 |
$221.94 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
15,034 |
14,416 |
$220.22 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,774 |
1,741 |
$211.08 |
| 71101 |
|
186 |
181 |
$204.67 |
| 82985 |
|
207 |
200 |
$193.37 |
| 82785 |
|
26 |
26 |
$184.64 |
| 82627 |
|
40 |
40 |
$183.45 |
| 77080 |
|
12 |
12 |
$181.37 |
| 80230 |
|
129 |
128 |
$169.95 |
| 86141 |
|
326 |
318 |
$162.74 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
397 |
349 |
$158.57 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,705 |
2,966 |
$155.85 |
| 86256 |
|
91 |
87 |
$154.04 |
| 87015 |
|
611 |
493 |
$150.68 |
| 86645 |
|
145 |
145 |
$140.48 |
| 86580 |
|
29 |
28 |
$140.18 |
| C9399 |
Unclassified drugs or biologicals |
257 |
256 |
$139.55 |
| 73020 |
|
58 |
55 |
$136.51 |
| 84681 |
|
82 |
82 |
$134.00 |
| 88720 |
|
289 |
244 |
$132.86 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,585 |
3,411 |
$130.64 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
15 |
12 |
$128.79 |
| 86364 |
|
284 |
255 |
$127.25 |
| 82610 |
|
159 |
148 |
$125.81 |
| J1956 |
Injection, levofloxacin, 250 mg |
119 |
117 |
$121.36 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
282 |
282 |
$119.67 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,396 |
1,156 |
$110.85 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
2,197 |
2,091 |
$110.21 |
| G0009 |
Administration of pneumococcal vaccine |
91 |
91 |
$108.06 |
| 82010 |
|
589 |
544 |
$107.03 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
399 |
389 |
$105.42 |
| C1730 |
Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) |
27 |
27 |
$104.16 |
| 90461 |
|
26 |
25 |
$102.96 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
7,705 |
7,154 |
$102.96 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
382 |
332 |
$97.48 |
| 72040 |
|
71 |
70 |
$95.71 |
| 90634 |
|
12 |
12 |
$94.61 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
12 |
12 |
$91.56 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
25 |
25 |
$84.93 |
| J7642 |
Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
116 |
115 |
$83.69 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
240 |
237 |
$82.90 |
| 82247 |
|
151 |
119 |
$81.58 |
| J2060 |
Injection, lorazepam, 2 mg |
1,667 |
1,486 |
$80.50 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
5,592 |
4,858 |
$78.56 |
| 86146 |
|
51 |
31 |
$72.77 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
678 |
635 |
$71.73 |
| 86225 |
|
25 |
25 |
$69.51 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
901 |
802 |
$67.94 |
| 72082 |
|
68 |
68 |
$67.04 |
| 74021 |
|
66 |
66 |
$66.12 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
426 |
335 |
$64.07 |
| 82157 |
|
27 |
27 |
$61.48 |
| 85347 |
|
211 |
150 |
$53.85 |
| J7070 |
Infusion, d5w, 1000 cc |
329 |
270 |
$52.36 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
6,096 |
4,663 |
$47.13 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
5,224 |
3,599 |
$47.08 |
| 82553 |
|
16 |
14 |
$44.07 |
| J7510 |
Prednisolone oral, per 5 mg |
614 |
548 |
$43.50 |
| 84520 |
|
26 |
26 |
$43.41 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
156 |
150 |
$41.01 |
| 31231 |
|
29 |
29 |
$40.11 |
| 83721 |
|
103 |
102 |
$37.20 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
192 |
137 |
$32.12 |
| 72070 |
|
12 |
12 |
$30.75 |
| 84300 |
|
13 |
12 |
$28.65 |
| 83498 |
|
14 |
14 |
$28.53 |
| J1953 |
Injection, levetiracetam, 10 mg |
72 |
65 |
$27.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
138 |
137 |
$26.29 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
51 |
51 |
$26.14 |
| 82626 |
|
13 |
13 |
$25.01 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
43 |
41 |
$22.68 |
| 82390 |
|
24 |
24 |
$22.30 |
| J2305 |
Injection, nitroglycerin, 5 mg |
362 |
339 |
$19.54 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,250 |
1,096 |
$17.29 |
| C9153 |
Injection, amisulpride, 1 mg |
39 |
39 |
$16.38 |
| 82948 |
|
16 |
15 |
$16.17 |
| 85613 |
|
16 |
14 |
$15.80 |
| 84134 |
|
94 |
93 |
$15.02 |
| J3411 |
Injection, thiamine hcl, 100 mg |
174 |
158 |
$13.42 |
| J3480 |
Injection, potassium chloride, per 2 meq |
72 |
28 |
$12.48 |
| 72110 |
|
49 |
49 |
$11.55 |
| J3360 |
Injection, diazepam, up to 5 mg |
86 |
77 |
$11.42 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
28 |
24 |
$11.24 |
| 82657 |
|
64 |
64 |
$10.86 |
| J1940 |
Injection, furosemide, up to 20 mg |
85 |
75 |
$10.63 |
| 82951 |
|
13 |
13 |
$8.84 |
| 84157 |
|
12 |
12 |
$8.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
142 |
121 |
$5.36 |
| 82465 |
|
102 |
100 |
$5.22 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
66 |
66 |
$4.27 |
| 82952 |
|
13 |
13 |
$3.40 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
44 |
38 |
$3.30 |
| J1815 |
Injection, insulin, per 5 units |
339 |
269 |
$3.02 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
152 |
148 |
$1.46 |
| A6448 |
Light compression bandage, elastic, knitted/woven, width less than three inches, per yard |
24 |
24 |
$1.43 |
| 82009 |
|
28 |
27 |
$1.03 |
| 82140 |
|
12 |
12 |
$1.00 |
| J1805 |
Injection, esmolol hydrochloride, 10 mg |
25 |
25 |
$0.09 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
158 |
151 |
$0.08 |
| 91300 |
|
23 |
21 |
$0.04 |
| 99080 |
|
7,397 |
1,339 |
$0.00 |
| 73000 |
|
13 |
12 |
$0.00 |
| J1643 |
Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units |
26 |
25 |
$0.00 |
| 83695 |
|
13 |
13 |
$0.00 |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
16 |
16 |
$0.00 |
| 80321 |
|
54 |
54 |
$0.00 |
| 87075 |
|
14 |
13 |
$0.00 |
| 86200 |
|
14 |
14 |
$0.00 |
| 74170 |
|
13 |
13 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
14 |
14 |
$0.00 |
| 73070 |
|
14 |
14 |
$0.00 |
| 83718 |
|
13 |
13 |
$0.00 |
| 80299 |
|
15 |
15 |
$0.00 |
| 90748 |
|
16 |
16 |
$0.00 |
| 87184 |
|
12 |
12 |
$0.00 |
| G0010 |
Administration of hepatitis b vaccine |
12 |
12 |
$0.00 |
| 84446 |
|
12 |
12 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
13 |
12 |
$0.00 |
| 73660 |
|
13 |
13 |
$0.00 |
| 70544 |
|
54 |
54 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
92 |
75 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
13 |
12 |
$0.00 |